Publications by Medical Specialty - Hematologists
These publications were authored or co-authored by Quest Diagnostics staff.
- Adult Medicine
- Clinical and Lab healthcare professionals
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Family medicine practitioners
- General Health and Wellness
- Geriatrics/Age Management
- Health Information Technology
- Infectious Disease
- Internal Medicine
- Nurse practitioners
- Pathology, Anatomic
- Pathology, Laboratory Medicine
- Physician assistants
- Prescription Drug Monitoring
- Primary Care
- Sports Medicine
- Toxicology/Pain Management
- Women's Health/OB/GYN
False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
Authors: Sahud M, Zhukov O, Mo K, Popov J, Dlott J.
New and known beta-thalassemia determinants masked by known and new delta gene defects [Hb A(2)-Ramallah or delta6(A3)Glu-->Gln, GAG>>CAG].
Authors: Phylipsen M, Harteveld CL, de MM, Gallivan MV, Arkesteijn SG, Luo HY, Chui DH, Giordano PC.
Occurrence of common and rare delta-globin gene defects in two multiethnic populations: thirteen new mutations and the significance of delta-globin gene defects in beta-thalassemia diagnostics.
Authors: Phylipsen M, Gallivan MV, Arkesteijn SG, Harteveld CL, Giordano PC.
Int J Lab Hematol. 2011;33:85-91.
'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
Authors: Pierangeli SS, de Groot PG, Dlott J, Favaloro E, Harris EN, Lakos G, Ortel T, Meroni PL, Otomo K, Pengo V, Tincani A, Wong R, Roubey R.
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study.
Authors: Richardson PG, Chanan-Khan AA, Lonial S, Krishnan AY, Carroll MP, Alsina M, Albitar M, Berman D, Messina M, Anderson KC.
Br J Haematol. 2011;153:729-740.
Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach.
Authors: Giardine B, Borg J, Higgs DR, Peterson KR, Philipsen S, Maglott D, Singleton BK, Anstee DJ, Basak AN, Clark B, Costa FC, Faustino P, Fedosyuk H, Felice AE, Francina A, Galanello R, Gallivan MV, Georgitsi M, Gibbons RJ, Giordano PC, Harteveld CL, Hoyer JD,
Nat Genet. 2011;43:295-301.
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.
Authors: Lee TS, Kantarjian H, Ma W, Yeh CH, Giles F, Albitar M.
PLoS One. 2011;6:e23396.
Authors: Ma W, Zhang X, Wang X, Zhang Z, Yeh CH, Uyeji J, Albitar M.
Diagn Mol Pathol. 2011;20:34-39.